LauraPiddock Profile Banner
Laura Piddock 💙 Profile
Laura Piddock 💙

@LauraPiddock

Followers
10K
Following
8K
Media
431
Statuses
24K

Emeritus Microbiology Prof, Birmingham Uni, UK. Mother/daughter/sister/wife. #antibiotic, #AMR, #drug-resistance. Own views

UK
Joined October 2011
Don't wanna be here? Send us removal request.
@LauraPiddock
Laura Piddock 💙
2 months
Exploring the history and uncertain future of antibiotics
Tweet card summary image
bbc.co.uk
Listen to the latest episodes of Dangerous Miracle by Liam Shaw on BBC Sounds.
0
1
2
@gardp_amr
Global Antibiotic R&D Partnership (GARDP)
3 months
GARDP’s AntibioticDB, an open-access database cataloguing 3,000+ antibacterial agents, has just been updated with a new feature: compound pages now display 2D chemical structures and molecular weights. A valuable tool for researchers working to address #AMR. 🔗 Explore the
0
2
3
@gardp_amr
Global Antibiotic R&D Partnership (GARDP)
3 months
🚀 Exciting news! Registration is now open for #ACC2026- a *FREE* virtual conference co-organized by GARDP & @BSACandJAC, joined this year by @ADVANCE__ID & @MahidolU. 🌍 Join us as we dive into the latest advances in antimicrobial discovery, development and access. 📅 4 & 5
0
7
11
@AlastairMcA30
Alastair McAlpine, MD
3 months
-154 million mothers didn’t have to cry over a child’s grave. - 10.2 BILLION years of life added. - Unquantifiable suffering of children (pain, paralysis, seizures, pneumonia, etc) averted. Vaccines are an absolute good.
@DrCatharineY
Dr. Catharine Young
3 months
Staggering numbers by the Lancet. Vaccinations have: - Averted 154 million deaths - For every death averted, 66 years of full health were gained on average = 10.2 billion years total - Accounted for 40% of the observed decline in global infant mortality
17
94
322
@SouthAfricanASP
Marc Mendelson
3 months
what a wonderful antidote to the horrors of the world
0
2
3
@gardp_amr
Global Antibiotic R&D Partnership (GARDP)
4 months
Meet REVIVE, your global antimicrobial R&D community and platform🌍 Created by GARDP, REVIVE connects and supports researchers, clinicians and innovators working to address #AMR. It is where you can follow what is happening in antimicrobial R&D, learn from past breakthroughs and
0
5
6
@gardp_amr
Global Antibiotic R&D Partnership (GARDP)
4 months
#Bacteriophages could offer hope where antibiotics are failing, especially in #LMICs At a workshop hosted by the @GlobalAMRHub, GARDP and global experts discussed how to design trials that can scale, shape regulation through dialogue and ensure equity by involving the most
0
4
4
@gardp_amr
Global Antibiotic R&D Partnership (GARDP)
4 months
Syphilis is resurging with congenital cases rising too. At our upcoming REVIVE webinar, infectious disease experts will share what’s working, what’s not and why new treatments are urgently needed. 📅 19 August 2025, 17:00-18:30 CEST 📍 Online Register here:
0
12
15
@gardp_amr
Global Antibiotic R&D Partnership (GARDP)
5 months
📊 Inside AntibioticDB AntibioticDB holds data on 3,000+ antibacterial compounds—from traditional antibiotics to experimental therapies like phages and antivirulence agents🧬🦠📈🧪🔍 With new tools like wildcard search, chemical identifiers, and smarter filters, AntibioticDB is
revive.gardp.org
AntibioticDB is an open-access database that catalogues and describes known antibacterial agents, consolidating data from diverse sources that include the primary research literature, patents and...
0
8
9
@ESCMID
ESCMID
6 months
Call for individual research grants 2026📣 ESCMID offers research grants to conduct clinical studies, experimental animal studies, or a combination of approaches. For this year's call, the focus is on bacterial infections ⏰Apply by 10 Sept 💡Learn more: https://t.co/QY54fmF6kK
0
5
12
@gardp_amr
Global Antibiotic R&D Partnership (GARDP)
6 months
👏FDA accepts New Drug Application for zoliflodacin — an investigational first-in-class oral antibiotic for uncomplicated #gonorrhoea. 🌍 Developed in collaboration with @InnovivaSTx, it could become the first new oral antibiotic for gonorrhoea in over 30 years. 🔗 Read the
Tweet card summary image
gardp.org
    In laboratory studies, zoliflodacin has been shown to be active against Neisseria gonorrhoeae including multidrug-resistant strains. If approved, zoliflodacin could become the first ... Innoviva...
1
7
17
@gardp_amr
Global Antibiotic R&D Partnership (GARDP)
6 months
🎓 Are you an early-career researcher in clinical microbiology or infectious diseases? GARDP is offering 5 grants to attend a top postgraduate course by @ecraid and @ESCMID. 📅 28–30 October 2025 📍 Athens, Greece 🌍 Priority for applicants from low- and middle-income countries
0
4
6
@P_A_Bradford
Patricia Bradford
6 months
Check out this new scheme for Class D b-lactamases. SAND: a comprehensive annotation of class D β-lactamases using structural alignment-based numbering | Antimicrobial Agents and Chemotherapy
journals.asm.org
Class D β-lactamases (DBLs) form a large family with nearly 1,300 identified members in the β-Lactamase Database (Fig. S1, www.bldb.euhttp://www.bldb.eu/) (1). They are produced mainly by Gram-nega...
0
7
29
@gardp_amr
Global Antibiotic R&D Partnership (GARDP)
7 months
🎥 The #ACC2025 recording is now available! From resistance trends to PK/PD and clinical challenges, watch the full conference to catch key insights for researchers, clinicians, and AMR specialists. ▶️ Start watching:
Tweet card summary image
revive.gardp.org
This year, for the first time, we are providing quality-controlled transcription and translation into Spanish and Portuguese on all recordings. We hope you find this useful. Please let us know what...
0
4
5
@gardp_amr
Global Antibiotic R&D Partnership (GARDP)
7 months
🚨 This is Big! New GARDP research shows that people with multidrug-resistant infections in LMICs are not receiving the appropriate antibiotics because of large gaps in access. Improving access and developing new antibiotics must be a priority, 📖 Read the study 👇
1
9
24
@NatureRevMicro
Nature Reviews Microbiology
8 months
New online! The global resistance problem and the clinical antibacterial pipeline https://t.co/vvSCOImJ6L
3
34
80
@LauraPiddock
Laura Piddock 💙
8 months
Rapid tuberculosis diagnosis from respiratory or blood samples by a low cost, portable lab-in-tube assay | Science Translational Medicine
Tweet card summary image
science.org
A low complexity, portable lab-in-tube tuberculosis assay for resource-limited areas analyzes blood, saliva, and sputum with a handheld device.
1
14
36
@LauraPiddock
Laura Piddock 💙
8 months
Three million child deaths linked to drug resistance, study shows
Tweet card summary image
bbc.com
Children in Africa and South East Asia are most at risk from antibiotics medicines no longer working, a study suggests.
1
19
35